SPRY
Price
$8.35
Change
+$0.26 (+3.21%)
Updated
Apr 26, 6:59 PM EST
17 days until earnings call
TRDA
Price
$12.45
Change
+$0.09 (+0.73%)
Updated
Apr 26, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare trend and price SPRY vs TRDA

Header iconSPRY vs TRDA Comparison
Open Charts SPRY vs TRDABanner chart's image
ARS Pharmaceuticals
Price$8.35
Change+$0.26 (+3.21%)
Volume$339.34K
CapitalizationN/A
Entrada Therapeutics
Price$12.45
Change+$0.09 (+0.73%)
Volume$13.78K
CapitalizationN/A
View a ticker or compare two or three
SPRY vs TRDA Comparison Chart

Loading...

SPRYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
SPRY vs. TRDA commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPRY is a Hold and TRDA is a Hold.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (SPRY: $8.09 vs. TRDA: $12.36)
Brand notoriety: SPRY and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPRY: 66% vs. TRDA: 100%
Market capitalization -- SPRY: $805.79M vs. TRDA: $418.33M
SPRY [@Biotechnology] is valued at $805.79M. TRDA’s [@Biotechnology] market capitalization is $418.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPRY’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 1 green FA rating(s).

  • SPRY’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both SPRY and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPRY’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • SPRY’s TA Score: 3 bullish, 6 bearish.
  • TRDA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both SPRY and TRDA are a bad buy in the short-term.

Price Growth

SPRY (@Biotechnology) experienced а -4.15% price change this week, while TRDA (@Biotechnology) price change was +3.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.51%. For the same industry, the average monthly price growth was -3.37%, and the average quarterly price growth was +1265.61%.

Reported Earning Dates

SPRY is expected to report earnings on Aug 08, 2024.

TRDA is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+7.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for SPRY with price predictions.
OPEN
A.I.dvisor published
a Summary for TRDA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SPRY($781M) has a higher market cap than TRDA($415M). SPRY YTD gains are higher at: 47.628 vs. TRDA (-18.091).
SPRYTRDASPRY / TRDA
Capitalization781M415M188%
EBITDAN/AN/A-
Gain YTD47.628-18.091-263%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
SPRYTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
SPRYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAMVX16.710.02
+0.12%
MoA Mid Cap Value Fund
AZEMX10.65-0.01
-0.09%
Alger Emerging Markets Z
VGYAX26.14-0.04
-0.15%
Vanguard Global Wellesley Income Admiral
ABCVX21.43-0.07
-0.33%
American Beacon The London Co Inc Eq Inv
MITJX34.78-0.18
-0.51%
MFS Massachusetts Investors Tr R6

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-2.06%
LPCN - SPRY
63%
Loosely correlated
+2.48%
SEEL - SPRY
39%
Loosely correlated
-5.12%
TSVT - SPRY
37%
Loosely correlated
+0.47%
HSTO - SPRY
34%
Loosely correlated
N/A
TRDA - SPRY
31%
Poorly correlated
-0.56%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with TRVI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then TRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-0.56%
TRVI - TRDA
35%
Loosely correlated
-4.15%
OVID - TRDA
34%
Loosely correlated
-5.08%
ARDX - TRDA
33%
Loosely correlated
-1.87%
FOLD - TRDA
32%
Poorly correlated
-3.51%
PCVX - TRDA
31%
Poorly correlated
-0.40%
More